The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback